Evolution of Bone Grafting: Bone Grafts and Tissue Engineering Strategies for Vascularized Bone Regeneration

Kaitlyn S. Griffin, Korbin M. Davis, Todd O. McKinley, Jeffrey O. Anglen, T.M. Gabriel Chu, Joel D. Boerckel, Melissa Kacena

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

The regeneration of bone in segmental defects has historically been a challenge in the orthopedic field. In particular, a lack of vascular supply often leads to nonunion and avascular necrosis. While the gold standard of clinical care remains the autograft, this approach is limited for large bone defects. Therefore, allograft bone is often required for defects of critical size though a high complication rate is directly attributable to their limited ability to revitalize, revascularize, and remodel resulting in necrosis and re-fracture. However, emerging insights into the mechanisms of bone healing continue to expand treatment options for bony defects to include synthetic materials, growth factors, and cells. The success of such strategies hinges on fabricating an environment that can mimic the body’s natural healing process, allowing for vascularization, bridging, and remodeling of bone. Biological, chemical, and engineering techniques have been explored to determine the appropriate materials and factors for potential use. This review will serve to highlight some of the historical and present uses of allografts and autografts and current strategies in bone tissue engineering for the treatment for bony defects, with particular emphasis on vascularization.

Original languageEnglish (US)
Pages (from-to)232-244
Number of pages13
JournalClinical Reviews in Bone and Mineral Metabolism
Volume13
Issue number4
DOIs
StatePublished - Dec 1 2015

Fingerprint

Bone Regeneration
Bone Transplantation
Tissue Engineering
Transplants
Bone and Bones
Autografts
Allografts
Necrosis
Chemical Engineering
Bioengineering
Bone Remodeling
Standard of Care
Orthopedics
Blood Vessels
Intercellular Signaling Peptides and Proteins
Therapeutics

Keywords

  • Allograft
  • Autograft
  • Bone tissue engineering
  • Endothelial cells
  • Growth factors
  • Mesenchymal stem cells
  • Scaffold
  • Vascularization

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Orthopedics and Sports Medicine

Cite this

Evolution of Bone Grafting : Bone Grafts and Tissue Engineering Strategies for Vascularized Bone Regeneration. / Griffin, Kaitlyn S.; Davis, Korbin M.; McKinley, Todd O.; Anglen, Jeffrey O.; Chu, T.M. Gabriel; Boerckel, Joel D.; Kacena, Melissa.

In: Clinical Reviews in Bone and Mineral Metabolism, Vol. 13, No. 4, 01.12.2015, p. 232-244.

Research output: Contribution to journalArticle

Griffin, Kaitlyn S. ; Davis, Korbin M. ; McKinley, Todd O. ; Anglen, Jeffrey O. ; Chu, T.M. Gabriel ; Boerckel, Joel D. ; Kacena, Melissa. / Evolution of Bone Grafting : Bone Grafts and Tissue Engineering Strategies for Vascularized Bone Regeneration. In: Clinical Reviews in Bone and Mineral Metabolism. 2015 ; Vol. 13, No. 4. pp. 232-244.
@article{4301d6d2212746d78b8c39469e6bd399,
title = "Evolution of Bone Grafting: Bone Grafts and Tissue Engineering Strategies for Vascularized Bone Regeneration",
abstract = "The regeneration of bone in segmental defects has historically been a challenge in the orthopedic field. In particular, a lack of vascular supply often leads to nonunion and avascular necrosis. While the gold standard of clinical care remains the autograft, this approach is limited for large bone defects. Therefore, allograft bone is often required for defects of critical size though a high complication rate is directly attributable to their limited ability to revitalize, revascularize, and remodel resulting in necrosis and re-fracture. However, emerging insights into the mechanisms of bone healing continue to expand treatment options for bony defects to include synthetic materials, growth factors, and cells. The success of such strategies hinges on fabricating an environment that can mimic the body’s natural healing process, allowing for vascularization, bridging, and remodeling of bone. Biological, chemical, and engineering techniques have been explored to determine the appropriate materials and factors for potential use. This review will serve to highlight some of the historical and present uses of allografts and autografts and current strategies in bone tissue engineering for the treatment for bony defects, with particular emphasis on vascularization.",
keywords = "Allograft, Autograft, Bone tissue engineering, Endothelial cells, Growth factors, Mesenchymal stem cells, Scaffold, Vascularization",
author = "Griffin, {Kaitlyn S.} and Davis, {Korbin M.} and McKinley, {Todd O.} and Anglen, {Jeffrey O.} and Chu, {T.M. Gabriel} and Boerckel, {Joel D.} and Melissa Kacena",
year = "2015",
month = "12",
day = "1",
doi = "10.1007/s12018-015-9194-9",
language = "English (US)",
volume = "13",
pages = "232--244",
journal = "Clinical Reviews in Bone and Mineral Metabolism",
issn = "1534-8644",
publisher = "Humana Press",
number = "4",

}

TY - JOUR

T1 - Evolution of Bone Grafting

T2 - Bone Grafts and Tissue Engineering Strategies for Vascularized Bone Regeneration

AU - Griffin, Kaitlyn S.

AU - Davis, Korbin M.

AU - McKinley, Todd O.

AU - Anglen, Jeffrey O.

AU - Chu, T.M. Gabriel

AU - Boerckel, Joel D.

AU - Kacena, Melissa

PY - 2015/12/1

Y1 - 2015/12/1

N2 - The regeneration of bone in segmental defects has historically been a challenge in the orthopedic field. In particular, a lack of vascular supply often leads to nonunion and avascular necrosis. While the gold standard of clinical care remains the autograft, this approach is limited for large bone defects. Therefore, allograft bone is often required for defects of critical size though a high complication rate is directly attributable to their limited ability to revitalize, revascularize, and remodel resulting in necrosis and re-fracture. However, emerging insights into the mechanisms of bone healing continue to expand treatment options for bony defects to include synthetic materials, growth factors, and cells. The success of such strategies hinges on fabricating an environment that can mimic the body’s natural healing process, allowing for vascularization, bridging, and remodeling of bone. Biological, chemical, and engineering techniques have been explored to determine the appropriate materials and factors for potential use. This review will serve to highlight some of the historical and present uses of allografts and autografts and current strategies in bone tissue engineering for the treatment for bony defects, with particular emphasis on vascularization.

AB - The regeneration of bone in segmental defects has historically been a challenge in the orthopedic field. In particular, a lack of vascular supply often leads to nonunion and avascular necrosis. While the gold standard of clinical care remains the autograft, this approach is limited for large bone defects. Therefore, allograft bone is often required for defects of critical size though a high complication rate is directly attributable to their limited ability to revitalize, revascularize, and remodel resulting in necrosis and re-fracture. However, emerging insights into the mechanisms of bone healing continue to expand treatment options for bony defects to include synthetic materials, growth factors, and cells. The success of such strategies hinges on fabricating an environment that can mimic the body’s natural healing process, allowing for vascularization, bridging, and remodeling of bone. Biological, chemical, and engineering techniques have been explored to determine the appropriate materials and factors for potential use. This review will serve to highlight some of the historical and present uses of allografts and autografts and current strategies in bone tissue engineering for the treatment for bony defects, with particular emphasis on vascularization.

KW - Allograft

KW - Autograft

KW - Bone tissue engineering

KW - Endothelial cells

KW - Growth factors

KW - Mesenchymal stem cells

KW - Scaffold

KW - Vascularization

UR - http://www.scopus.com/inward/record.url?scp=84948577795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84948577795&partnerID=8YFLogxK

U2 - 10.1007/s12018-015-9194-9

DO - 10.1007/s12018-015-9194-9

M3 - Article

AN - SCOPUS:84948577795

VL - 13

SP - 232

EP - 244

JO - Clinical Reviews in Bone and Mineral Metabolism

JF - Clinical Reviews in Bone and Mineral Metabolism

SN - 1534-8644

IS - 4

ER -